Kwang Lee
Finanzdirektor/CFO bei SquareX Pharmaceuticals Corp.
Profil
Kwang Lee is currently a Partner at Ravix Group, Inc. and the Chief Financial Officer at SquareX Pharmaceuticals Corp.
Previously, he worked as a Senior Director at Bayhill Therapeutics, Inc. Mr. Lee obtained an undergraduate degree and an MBA from San Jose State University.
Aktive Positionen von Kwang Lee
| Unternehmen | Position | Beginn |
|---|---|---|
SquareX Pharmaceuticals Corp.
 SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Finanzdirektor/CFO | 01.10.2022 |
Ravix Group, Inc.
 Ravix Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kingsway Financial Services, Inc., Ravix Group, Inc. provides accounting, financial and human resources consulting services. The company is based in San Jose, CA. The company was founded by Dan Saccani. Dan Saccani has been the CEO since incorporation. Ravix Group was acquired by Kingsway Financial Services, Inc. on October 04, 2021 for $15.50 million. | Corporate Officer/Principal | 01.01.2012 |
Ehemalige bekannte Positionen von Kwang Lee
| Unternehmen | Position | Ende |
|---|---|---|
Bayhill Therapeutics, Inc.
 Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Kwang Lee
| San Jose State University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Health Technology |
Ravix Group, Inc.
Ravix Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kingsway Financial Services, Inc., Ravix Group, Inc. provides accounting, financial and human resources consulting services. The company is based in San Jose, CA. The company was founded by Dan Saccani. Dan Saccani has been the CEO since incorporation. Ravix Group was acquired by Kingsway Financial Services, Inc. on October 04, 2021 for $15.50 million. | Commercial Services |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |